UMIN-CTR History

UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials


Unique ID issued by UMIN UMIN000001298
Receipt No. R000001577
Scientific Title Phase II study of exemestane with doxorubicin plus paclitaxel (AP) followed by weekly paclitaxel (wP) as primary systemic chemotherapy for hormone-sensitive and HER2-negative postmenopausal breast cancer (SBCCSG-13 EAPAC)
Date of disclosure of the study information 2008/08/05
Last modified on 2018/12/18 19:55:59

No. Disposal Last modified on Item of update
1 Insert 2008/08/04 23:21:30
2 Update 2009/01/06 20:49:19 Recruitment status
3 Update 2011/08/04 12:31:48 Post marketing survey by drug manufacture etc., specified by Japanese law.
4 Update 2013/08/04 20:10:59 Recruitment status
Publication of results
5 Update 2017/11/30 18:03:48 UMIN ID1
6 Update 2018/12/18 19:55:59 Recruitment status
Date of protocol fixation
Anticipated trial start date
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Contact us.